日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correspondence to letter to the editor on "Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway"

致编辑的信函，主题为“基于分区代谢特征和致癌信号通路的肝细胞癌分子分型”

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2025.0760
Aoki, Tomoko; Nishida, Naoshi; Kudo, Masatoshi
信号转导
代谢
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Correspondence to editorial on "Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway"

致编辑的信函，主题为“基于分区代谢特征和致癌信号通路的肝细胞癌分子分型”

期刊:Clinical and Molecular Hepatology
影响因子:16.9
doi:10.3350/cmh.2025.0435
Aoki, Tomoko; Nishida, Naoshi; Kudo, Masatoshi
肿瘤
肿瘤免疫
信号转导
代谢
细胞生物学
发表日期：2026
文献求助 收藏

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial

不可切除肝细胞癌患者接受 tremelimumab 联合 durvalumab 治疗和 durvalumab 单药治疗的免疫介导不良事件和总生存期：HIMALAYA III 期随机临床试验

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000001385
Lau, George; Sangro, Bruno; Cheng, Ann-Lii; Kudo, Masatoshi; Kelley, Robin Kate; Tak, Won Young; Gasbarrini, Antonio; Reig, Maria; Lim, Ho Yeong; Tougeron, David; De Toni, Enrico N; Tam, Vincent C; Mody, Kabir; Gong, Jun; Crysler, Oxana V; Sukeepaisarnjaroen, Wattana; Lipatov, Oleg; Morimoto, Manabu; Archambeaud, Isabelle; Burgio, Valentina; Phuong, Le Thi Tuyet; Chao, Yee; Peron, Jean-Marie; Berres, Marie-Luise; Ko, Yoo-Joung; Ran, Di; Makowsky, Mallory; Negro, Alejandra; Abou-Alfa, Ghassan K
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Full aspiration technique using a 7-Fr double-pigtail stent for endoscopic ultrasound-guided pancreatic fluid drainage of a pancreatic pseudocyst

采用7Fr双猪尾支架进行内镜超声引导下胰腺假性囊肿胰液引流的完全抽吸技术

期刊:Endoscopy
影响因子:12.8
doi:10.1055/a-2779-3430
Omoto, Shunsuke; Takenaka, Mamoru; Yoshida, Akihiro; Fukunishi, Kae; Tanaka, Hidekazu; Komeda, Yoriaki; Kudo, Masatoshi
发表日期：2026
文献求助 收藏

Rescue multihole metal stent placement to prevent stent migration after endoscopic ultrasound-guided hepaticogastrostomy

内镜超声引导下肝胃吻合术后，采用多孔金属支架进行补救性置入以防止支架移位

期刊:Endoscopy
影响因子:12.8
doi:10.1055/a-2792-9907
Hara, Akane; Minaga, Kosuke; Otsuka, Yasuo; Takenaka, Mamoru; Kudo, Masatoshi
发表日期：2026
文献求助 收藏

The usefulness of the novel 0.018-inch dedicated uneven double-lumen cannula for endoscopic ultrasound-guided hepaticogastrostomy using a 22-gauge needle

新型0.018英寸专用不规则双腔套管在内镜超声引导下使用22号针进行肝胃吻合术中的应用价值

期刊:Endoscopy
影响因子:12.8
doi:10.1055/a-2802-4849
Takenaka, Mamoru; Kawamoto, Hirofumi; Fukunaga, Tomohiro; Sakano, Yuka; Kurimoto, Masayuki; Lee, Tae Hoon; Kudo, Masatoshi
发表日期：2026
文献求助 收藏

Real-world patient characteristics and utilization patterns in patients with cholangiocarcinoma who received pemigatinib in the United States of America

美国接受培米替尼治疗的胆管癌患者的真实世界患者特征和使用模式

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2026.9753
Joshi, Spruha; Jing, Mengni; Wheeler-Martin, Katherine; Shah, Pooja; Davis, Corey S; DiMaggio, Charles J; Cerdá, Magdalena; Aoki, Tomoko; Tsurusaki, Masakatsu; Nishida, Naoshi; Morita, Masahiro; Chishina, Hirokazu; Takita, Masahiro; Hagiwara, Satoru; Minami, Yasunori; Ueshima, Kazuomi; Kudo, Masatoshi; Verma, S; Hughes, A; Engel-Nitz, NM; Steiger, C; Rodriguez, M; Blecker, M
胆管癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A Phase 1b Study of Lenvatinib plus Nivolumab in Patients with Unresectable Hepatocellular Carcinoma

一项针对不可切除肝细胞癌患者的乐伐替尼联合纳武利尤单抗的1b期研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000549681
Ikeda, Masafumi; Kudo, Masatoshi; Motomura, Kenta; Okusaka, Takuji; Kato, Naoya; Hisai, Takashi; Ikezawa, Hiroki; Shiba, Sari; Hoshi, Taisuke; Kuroda, Masataka; Kumada, Hiromitsu; Kobayashi, Masahiro
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

A Newly Launched Nationwide Database Revealed Real-World Evidence on Systemic Therapy for Unresectable Hepatocellular Carcinoma in Japan: Hepatoma Registry of Integrating and Aggregating Electronic Health Record (HERITAGE)

日本新推出的全国性数据库揭示了不可切除肝细胞癌系统治疗的真实世界证据：整合和汇总电子健康记录的肝癌登记处（HERITAGE）

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000546862
Asaoka, Yoshinari; Tateishi, Ryosuke; Yamada, Yasuhide; Kokudo, Takashi; Saito, Akiko; Hasegawa, Kiyoshi; Iijima, Hiroko; Kato, Naoya; Shimada, Mitsuo; Hatano, Etsuro; Fukumoto, Takumi; Murakami, Takamichi; Yano, Hirohisa; Yoshimitsu, Kengo; Kurosaki, Masayuki; Sakamoto, Michiie; Matsuyama, Yutaka; Kudo, Masatoshi; Miyata, Hiroaki; Kokudo, Norihiro
细胞生物学
肿瘤
肝癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Primary Analysis of a Phase II Study of Atezolizumab plus Bevacizumab for TACE-Unsuitable Patients with Tumor Burden beyond Up-To-Seven Criteria in Intermediate-Stage Hepatocellular Carcinoma: REPLACEMENT Study

一项针对不适合接受经导管动脉化疗栓塞术（TACE）且肿瘤负荷超过“Up-To-7”标准的中晚期肝细胞癌患者的阿特珠单抗联合贝伐珠单抗治疗的II期研究的主要分析：REPLACEMENT研究

期刊:Liver Cancer
影响因子:9.1
doi:10.1159/000546899
Kudo, Masatoshi; Ueshima, Kazuomi; Tsuchiya, Kaoru; Yamashita, Tatsuya; Shimose, Shigeo; Numata, Kazushi; Kodama, Yuzo; Itoh, Shinji; Tanaka, Yasuhito; Kuroda, Hidekatsu; Aikata, Hiroshi; Hiraoka, Atsushi; Moriguchi, Michihisa; Tateishi, Ryosuke; Ogasawara, Sadahisa; Yamamoto, Kouji; Ikeda, Masafumi
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏